SAMHD1 and hepatocellular carcinoma: Mechanistically, SAMHD1 interacts with the nuclear cohesin complex to stall mitosis, independent of its deoxynucleotide triphosphohydrolase dNTPase activity, positioning SAMHD1 as a potential therapeutic target in HCC.